Viewing data from:

POLYETHYLENE GLYCOL 3350

ANDA

POLYETHYLENE GLYCOL 3350 | A078915 | MYLAN PHARMACEUTICALS INC

2 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 1 NDC

Highest NADAC/Unit

$1.13

per ea

Lowest NADAC/Unit

$1.13

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
51079030630POLYETHYLENE GLYCOL 3350 POWD	$1.13	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs

4 active API suppliers hold Drug Master Files for this ingredient.

BASF CORPPOLYETHYLENE GLYCOL 3350

DMF 169462003

AVESTA PHARMA PVT LTDPOLYETHYLENE GLYCOL 3350 USP

DMF 274192013

CLARIANT CHEMICALS (HUIZHOU) LTDPOLYETHYLENE GLYCOL 3350 USP/NF

DMF 323552018

PHARCOS SPECIALITY LTDPOLYETHYLENE GLYCOL 3350 USP

DMF 413202025

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Oct 14, 2009	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — 17GM/PACKET

0 patents0 exclusivities▴

FOR SOLUTION;ORAL | Approved: Oct 6, 2009

No patent or exclusivity listings for this strength.

#002 — 17GM/SCOOPFUL

0 patents0 exclusivities▾

FOR SOLUTION;ORAL | Approved: Oct 6, 2009